Skip to main content
. 2009 Jan 8;8:1. doi: 10.1186/1475-2840-8-1

Table 2.

Fasting lipids, lipoproteins and apolipoproteins in the three periods of treatment

(A) Diet (B) Diet plus Fluvastatin 80 mg (C) Diet plus Fluvastatin 80 mg plus Omacor 4 g
Total Cholesterolac 259 ± 55 174 ± 35 203 ± 54

LDL cholesterolac 157 ± 47 103 ± 25 127 ± 30

HDL cholesterolbc 34 ± 9 32 ± 10 40 ± 11

Non-HDL cholac 225 ± 55 142 ± 35 163 ± 54

Triglyceridesc 337 ± 153 263 ± 226 195 ± 129

VLDL triglyceridesc 289 ± 160 224 ± 222 136 ± 118

Tg/HDL-chol ratioc 4.80 ± 2.69 4.39 ± 5.10 2.23 ± 1.56

Apo A-1 113 ± 24 107 ± 41 124 ± 26

Apo B100ac 126 ± 34 89 ± 16 82 ± 16

Apo B48c 5.81 ± 2.59 4.12 ± 2.78 3.07 ± 1.47

Apo C-IIac 20.4 ± 6.1 18.1 ± 5.6 15.8 ± 6.8

Apo C-III a 18.7 ± 5.7 12.9 ± 3.5 12.8 ± 4.7

C-II/C-III ratio 1.13 ± 0.31 1.41 ± 0.29 1.30 ± 0.16

Data showed as mg/dL except apo B48, in mg/L.

a (A) vs (B) p < 0.05.

b (B) vs (C) p < 0.05.

c (A) vs (C) p < 0.05.